Injectable Anticoagulants Market, Global Outlook and Forecast 2023-2029

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragminﾮ], enoxaparin [Lovenoxﾮ]) and factor Xa inhibitors (fondaparinux [Arixtraﾮ]).
In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
This report aims to provide a comprehensive presentation of the global market for Injectable Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anticoagulants. This report contains market size and forecasts of Injectable Anticoagulants in global, including the following market information:
Global Injectable Anticoagulants Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Injectable Anticoagulants market was valued at US$ 6268.4 million in 2022 and is projected to reach US$ 7205.2 million by 2029, at a CAGR of 2.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market competition is intense. Sanofi, Genentech (Roche), Boehringer Ingelheim and Pfizer, etc. are the leaders of the industry, with about 68% market shares.
North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injectable Anticoagulants companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Anticoagulants Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Injectable Anticoagulants Market Segment Percentages, by Type, 2022 (%)
    Low-Molecular-Weight Heparin (LMWH)
    Direct Thrombin Inhibitor (DTI)
    Others
Global Injectable Anticoagulants Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Injectable Anticoagulants Market Segment Percentages, by Application, 2022 (%)
    VTE
    ACS/MI
    AF
    Others
Global Injectable Anticoagulants Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Injectable Anticoagulants Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Anticoagulants revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Injectable Anticoagulants revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sanofi
    Genentech (Roche)
    Boehringer Ingelheim
    Pfizer
    The Medicines Company
    Aspen
    Otsuka
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injectable Anticoagulants, market overview.
Chapter 2: Global Injectable Anticoagulants market size in revenue.
Chapter 3: Detailed analysis of Injectable Anticoagulants company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Anticoagulants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.